Santhera Pharmaceuticals Holding AG - Company Profile
Powered by 
All the sales intelligence you need on Santhera Pharmaceuticals Holding AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Santhera Pharmaceuticals Holding AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Santhera Pharmaceuticals Holding AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Santhera Pharmaceuticals Holding AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Santhera Pharmaceuticals Holding AG's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Thomas Meier
Chairman Executive BoardMr. Thomas Meier has been the Chairman of the company since 2022. Prior to this, he served as a Chief Executive Officer at Santhera from October 2011 to November 2019. Previously, he served as the Chief Scientific Officer from 2004 to 2011.
Dario Eklund
Chief Executive Officer Senior ManagementMr. Dario Eklund has been the Chief Executive Officer of the company since 2019. Prior to this, he served as the Chief Commercial Officer of Vifor Pharma. Mr. Eklund also served as the Vice President of Organogenesis, General Manager Switzerland of Sanofi. He served as Global Commercial Director, Biotechnology, Area Director, Eastern Europe & Israel and Area Manager, Eastern European countries of Novartis.
Catherine Isted
Chief Financial Officer Senior ManagementMs. Catherine Isted has been the Chief Financial Officer of the company since 2025. Previously, she served as the Chief Financial Officer at BenevolentAI. Prior to this, she served as the Chief Executive Officer and Chief Financial Officer of ReNeuron Group Plc. She also held the role of Head of Corporate Development and Investor Relations at Oxford Biomedica plc. Earlier, Ms. Catherine Isted spent 15 years in healthcare investment banking, holding senior roles at ABN AMRO, Morgan Stanley, Nomura, and Peel Hunt.
Marc Schrader
Chief Technology Officer Senior ManagementMr. Marc Schrader has been the Chief Technology Officer of the company since 2024. Prior to this, he served as the Head of Technical Development and Operations of the company from 2022 to 2024. Previously, he served in leadership roles at Tillotts Pharma AG, Actelion Pharmaceuticals Ltd and Janssen Pharmaceutica N.V.
Oliver P. Kronenberg
Chief Legal Officer; Secretary Senior ManagementMr. Oliver P. Kronenberg has been the Chief Legal Officer and Secretary of the company since 2024. Prior to this, he served as Head of Legal and Compliance at Vifor Pharma. Previously, he served as the General Counsel at Galenica.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer